UnitedHealth shares fall 4.2% as Medicare Advantage audit proposal raises concerns
Key Facts
UnitedHealth Group shares fell 4.2% to $373.47 in morning trading on November 18, 2026, according to Investing.com, which linked the decline to a federal proposal targeting Medicare Advantage plans. The move follows the Centers for Medicare & Medicaid Services, known as CMS, issuing the CRUSH proposal on November 16 to combat fraud, waste and abuse in Medicare, Medicaid, CHIP and Marketplace programs. CMS estimated the proposal could save taxpayers about $90 billion over the next 10 years. A prominent part of the measures focuses on auditing Medicare Advantage payments, potentially subjecting insurers that manage these plans to tighter reviews of beneficiary data. Investing.com said CMS’s estimate points to recovering about $9 billion per payment year across the sector through the proposed audit approach.
The proposal includes strengthening Risk Adjustment Data Validation audits, known as RADV, in Medicare Advantage. CMS said the program is responsible for $21 billion in annual overpayments due to improper inflation of beneficiaries’ risk scores. The rule proposes applying audit findings extrapolation to plan years starting in 2018, broadening the range of years that could be subject to payment reviews. It also proposes requiring companies to repay amounts deemed improper under a mechanism set by CMS. In its quarterly filing, UnitedHealth said CMS and the inspector general’s office selected some of its domestic plans for RADV audits, and that the findings could lead to retroactive adjustments to health plan payments. The company added that some of its operations had been reviewed for compliance with coding requirements in the Medicare risk adjustment model.
The proposal also covers fraud reporting and payment suspension mechanisms. CMS proposes making referrals by Medicare Advantage companies and Part D plan sponsors mandatory for suspected or confirmed cases of fraud, waste or abuse. It also includes expanding reporting on payment suspensions based on credible suspicions, extending the requirement from pharmacies to other providers and suppliers. CMS data show that only 46% of Medicare Part C and Part D contracts reported referrals in calendar year 2025. CMS also said only 19% of those contracts reported any payment suspension based on credible allegations of fraud in 2025. Seeking Alpha said the potential impact on Medicare Advantage companies could be substantial, but may unfold over time and be subject to litigation.
CMS estimated the proposed measures could generate savings of about $90 billion for taxpayers over the next 10 years, but the rule text also gives an estimate of about $379 million in costs between 2027 and 2036 for provisions that could be quantified. That estimate excludes transfers of more than $90 billion expected between the federal government and states or private entities. CMS said its current quantitative estimate is incomplete, placing the savings, costs and transfers among the proposal’s estimates rather than final results. CMS described CRUSH as a standalone, discretionary rule, not an annual payment rule. The agency said it intends to conduct this type of program integrity rulemaking annually in the future. It added that it received more than 560 comments and suggestions in response to a request for information issued in February 2026, and that some of those submissions helped shape the proposal.
The rule remains at the proposal stage, with CMS setting January 19, 2027, as the deadline for public comments. For the mandatory reporting requirements, the text proposes that they take effect 60 days after publication of the final rule, with implementation on January 1, 2028. The implementation date therefore depends on publication of the final version, while the stated deadline allows comments before the regulatory process is completed. The proposal comes as CMS says reporting of referrals and payment suspensions covers only a share of Part C and Part D contracts. UnitedHealth shares stood at $373.47 in morning trading on November 18, according to Investing.com.